Life ScienceCompany
ANI Pharmaceuticals M&A Summary
ANI Pharmaceuticals has acquired 14 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms.
ANI Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired Novitium Pharma for $164M. ANI Pharmaceuticals has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (86%) and medical products (15%).
ANI Pharmaceuticals Business Overview
Where is ANI Pharmaceuticals headquartered?
ANI Pharmaceuticals is headquartered in Baudette, Minnesota.
What is ANI Pharmaceuticals’ revenue?
ANI Pharmaceuticals disclosed revenue of 208M USD for 2020 and 207M USD for 2019.
How many employees does ANI Pharmaceuticals have?
ANI Pharmaceuticals has 369 employees.
What sector is ANI Pharmaceuticals in?
ANI Pharmaceuticals is a life science company.
When was ANI Pharmaceuticals founded?
ANI Pharmaceuticals was founded in 2001.
M&A Summary
-
M&A Total Activity14
- M&A Buy Activity14
- Total Sectors Invested 2
- Total Countries Invested 4
- M&A Buy/Sell Connections 11
- M&A Advisors 6